Renejix – Small Molecule CDMO (USA)
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by functional area. Renejix’s stand-alone analytical services for small molecules operates out of the Industrial Park Happaugue, NY and Central, Islip, locations. Download to learn more.
Direct-to-Patient Clinical Supply Services: Amid the surge in remote clinical studies, the imperative of facilitating direct-to-patient distribution of clinical supplies has gained…
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…
An array of advanced technologies at your disposal to address your molecule’s challenges and processing hurdles effectively, achieving the optimal dosage form.
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
